These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
313 related articles for article (PubMed ID: 19428302)
1. Is complement good or bad for cancer patients? A new perspective on an old dilemma. Markiewski MM; Lambris JD Trends Immunol; 2009 Jun; 30(6):286-92. PubMed ID: 19428302 [TBL] [Abstract][Full Text] [Related]
2. Cancer and the complement cascade. Rutkowski MJ; Sughrue ME; Kane AJ; Mills SA; Parsa AT Mol Cancer Res; 2010 Nov; 8(11):1453-65. PubMed ID: 20870736 [TBL] [Abstract][Full Text] [Related]
3. Complement as a Biological Tool to Control Tumor Growth. Macor P; Capolla S; Tedesco F Front Immunol; 2018; 9():2203. PubMed ID: 30319647 [TBL] [Abstract][Full Text] [Related]
5. Immune evasion by a staphylococcal complement inhibitor that acts on C3 convertases. Rooijakkers SH; Ruyken M; Roos A; Daha MR; Presanis JS; Sim RB; van Wamel WJ; van Kessel KP; van Strijp JA Nat Immunol; 2005 Sep; 6(9):920-7. PubMed ID: 16086019 [TBL] [Abstract][Full Text] [Related]
6. The expression of complement regulatory proteins by adult human oligodendrocytes. Scolding NJ; Morgan BP; Compston DA J Neuroimmunol; 1998 Apr; 84(1):69-75. PubMed ID: 9600710 [TBL] [Abstract][Full Text] [Related]
7. Staphylococcal complement inhibitors: biological functions, recognition of complement components, and potential therapeutic implications. Geisbrecht BV Adv Exp Med Biol; 2008; 632():221-36. PubMed ID: 19025125 [TBL] [Abstract][Full Text] [Related]
8. Protection of MLV vector particles from human complement. Breun S; Salmons B; Günzburg WH; Baumann JG Biochem Biophys Res Commun; 1999 Oct; 264(1):1-5. PubMed ID: 10527830 [TBL] [Abstract][Full Text] [Related]
12. Dual role of complement in tumour growth and metastasis (Review). Stover C Int J Mol Med; 2010 Mar; 25(3):307-13. PubMed ID: 20127033 [TBL] [Abstract][Full Text] [Related]
13. Inactivation of complement by recombinant human C3 derivatives. Spillner F; Kölln J; Bredehorst R Adv Exp Med Biol; 2006; 586():347-60. PubMed ID: 16893083 [No Abstract] [Full Text] [Related]
14. Complement-mediated lysis of cultured osteosarcoma cell lines using chimeric mouse/human TP-1 IgG1 and IgG3 antibodies. Olafsen T; Munthe Lund CK; Bruland OS; Sandlie I; Michaelsen TE Cancer Immunol Immunother; 1999 Oct; 48(7):411-8. PubMed ID: 10501855 [TBL] [Abstract][Full Text] [Related]
15. [The functional unity of the complement system and mononuclear phagocytes (author's transl)]. Bitter-Suermann D Verh Dtsch Ges Pathol; 1980; 64():63-76. PubMed ID: 7013340 [No Abstract] [Full Text] [Related]
16. A tumor-expressed inhibitor of the early but not late complement lytic pathway enhances tumor growth in a rat model of human breast cancer. Caragine TA; Okada N; Frey AB; Tomlinson S Cancer Res; 2002 Feb; 62(4):1110-5. PubMed ID: 11861390 [TBL] [Abstract][Full Text] [Related]